共 245 条
[1]
Burris KD(2002)Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors J Pharmacol Exp Ther 302 381-389
[2]
Molski TF(2007)The clinical global impressions scale: applying a research tool in clinical practice Psychiatry (Edgmont) 4 28-37
[3]
Xu C(2009)Quality of life in caregivers of patients with schizophrenia: a literature review Health Qual Life Outcomes 7 84-399
[4]
Ryan E(2003)Switching patients to aripiprazole from other antipsychotic agents: a multicenter randomized study Psychopharmacology 166 391-572
[5]
Tottori K(2013)Withdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: theoretical background and practical recommendations CNS Drugs 27 545-1203
[6]
Kikuchi T(2018)Global epidemiology and burden of schizophrenia: findings from the Global Burden of Disease Study 2016 Schizophr Bull 44 1195-995
[7]
Yocca FD(2008)Brain and plasma pharmacokinetics of aripiprazole in patients with schizophrenia: an [18F]fallypride PET study Am J Psychiatry 165 988-318
[8]
Molinoff PB(2018)The acute efficacy of antipsychotics in schizophrenia: a review of recent meta-analyses Ther Adv Psychopharmacol 8 303-743
[9]
Busner J(2007)Unique pharmacological profile of aripiprazole as the phasic component buster Psychopharmacology 191 741-90
[10]
Targum SD(2010)Suicide and schizophrenia: a systematic review of rates and risk factors J Psychopharmacol 24 81-644